The Use of Pharmacy Claims Data as an Early Indicator of Potential Bioequivalence Issues for Newly Launched Generic Medications

 

The Use of Pharmacy Claims Data as an Early Indicator of Potential Bioequivalence Issues for Newly Launched Generic Medications

This poster describes the use of Pharmacy Claims Data as an Early Indicator of Potential Bioequivalence Issues for Newly Launched Generic Medications.